Global Leading Market Research Publisher QYResearch announces the release of its latest report *“Portable Gamma Imager – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Portable Gamma Imager market, including market size, share, demand, industry development status, and forecasts for the next few years.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6093112/portable-gamma-imager
1. Executive Summary: Addressing Radiological Threat Localization & Nuclear Safety Gaps
The global Portable Gamma Imager market is experiencing accelerated growth, driven by escalating radiological security concerns, aging nuclear infrastructure, and the imperative for rapid emergency response to radioactive contamination incidents. According to QYResearch’s updated forecast, the market was valued at US589millionin2025∗∗andisprojectedtoreach∗∗US589millionin2025∗∗andisprojectedtoreach∗∗US 919 million by 2032, growing at a CAGR of 6.7% from 2026 to 2032.
For radiation safety officers, nuclear facility operators, and emergency responders, critical pain points include the inability of conventional dosimeters or survey meters to localize radioactive sources with spatial resolution and the time-consuming nature of manual scanning. Portable gamma imagers—compact, mobile devices combining gamma-ray detection with real-time imaging—address these gaps by visually overlaying radiation intensity onto optical scene images, enabling operators to pinpoint nuclide positions within seconds. Core technologies include scintillation detectors (NaI(Tl), CsI(Tl)) for energy discrimination, semiconductor sensors (CZT, HPGe) for superior energy resolution, and coded aperture or Compton camera designs for angular localization. Key applications span nuclear security (border monitoring, lost source recovery), nuclear facility monitoring (waste characterization, decommissioning), environmental surveying (legacy site assessment), and emergency response (orphan source detection, CBRN incidents).
Core technology keywords embedded throughout this analysis:
- Portable gamma imager (device category)
- Radiation detection (primary function)
- Radiological security (end-user domain)
- Real-time imaging (performance attribute)
- Nuclide localization (technical capability)
2. Technology Segmentation: Scintillator-Based, Semiconductor-Based & Hybrid Systems
The market is segmented by detection technology into Scintillator-Based Gamma Imagers, Semiconductor-Based Gamma Imagers, and Hybrid Systems.
Scintillator-Based Gamma Imagers currently dominate with approximately 54% of 2025 revenue, owing to their mature manufacturing base, lower cost (typical unit price $45,000–85,000), and reliable performance across medium-energy gamma spectra (100 keV – 2 MeV). Devices typically employ continuous or pixelated NaI(Tl) or CsI(Tl) crystals coupled to position-sensitive photomultiplier tubes (PSPMTs) or silicon photomultipliers (SiPMs). The primary limitation is modest energy resolution (typically 6–9% FWHM at 662 keV), which reduces isotopic discrimination capability in mixed-field environments.
Semiconductor-Based Gamma Imagers represent the fastest-growing segment (CAGR 9.3%), driven by superior energy resolution (1.5–3.5% FWHM at 662 keV for CdZnTe/CZT detectors) enabling precise nuclide identification even in complex spectral backgrounds. CZT-based portable gamma cameras are increasingly deployed for radiological security at special nuclear material (SNM) checkpoints, where discriminating weapons-grade plutonium from medical isotopes is critical. Unit pricing remains higher ($95,000–180,000) due to challenges in growing large-volume, high-resistivity CZT crystals. Recent advances in room-temperature semiconductor processing (2025–2026) have improved detector yield from 35% to 58%, modestly reducing per-unit costs.
Hybrid Systems combine both detector types—typically a scintillator for wide-field survey and a semiconductor for high-resolution spectroscopy—targeting advanced research laboratories and national security agencies. These systems account for approximately 18% market share but are growing at a slower CAGR (4.2%) due to higher complexity and weight.
Industry depth perspective – discrete vs. process manufacturing: Unlike continuous-process detector fabrication, portable gamma imagers follow a discrete manufacturing model. Hand-selected scintillation crystals or semiconductor wafers undergo individual characterization (light output, energy resolution, leakage current), followed by manual assembly of detector modules, electronics integration, and system-level calibration using certified radioactive sources (e.g., Cs-137, Co-60). This discrete approach ensures stringent quality control (each unit’s calibration certificate typically reports sensitivity, angular resolution, and energy resolution at 2–3 energies) but constains economies of scale. A typical production line can output 250–400 units annually at full capacity. Emerging automation in SiPM placement and digital pulse processing is reducing assembly time per unit from 18 hours to 12 hours (2024–2026 data).
3. Recent Market Data & Regulatory/Operational Drivers (Last 6 Months, 2025–2026)
a) Nuclear security spending trends: According to the International Atomic Energy Agency (IAEA) Nuclear Security Series 2026 mid-year report, global government spending on radiological detection equipment increased 12.4% year-over-year, driven by upgrades at 147 border crossings and 89 seaports identified as “high-risk for illicit trafficking.” At least 18 of these procurements explicitly specified portable gamma imagers for mobile deployment.
b) Nuclear decommissioning acceleration: The European Bank for Reconstruction and Development (EBRD) announced in February 2026 an additional €340 million for early closure and decommissioning of aging nuclear reactors (Bulgaria, Slovakia, Lithuania). Decommissioning requires extensive radiological characterization—a workflow where real-time imaging reduces survey time by 65–80% compared to contact dose rate mapping.
c) User case example – national nuclear laboratory (Idaho National Laboratory, US): In Q4 2025, INL deployed three semiconductor-based portable gamma imagers (CZT, 4π coded aperture) to characterize a legacy plutonium-contaminated glovebox scheduled for decommissioning. Conventional swiping and gamma spectroscopy required 36 person-hours to map 12 hotspots. The portable imagers completed the same survey in 7 hours (81% time reduction), with five additional low-activity areas detected that were missed by conventional methods. The laboratory subsequently issued a procurement recommendation for 12 additional units across its radiological facilities.
4. Application Segmentation: Tumor Imaging, Bone Scan, Cardiac Stress Test & Other
The report segments medical applications as Tumor Imaging, Bone Scan, Cardiac Stress Test, and Other (including thyroid uptake studies and sentinel lymph node detection). Notably, the original source list mixes medical molecular imaging (tumor, bone, cardiac) with non-medical applications—a segmental tension resolved below.
Tumor Imaging (primarily radiopharmaceutical-based using Tc-99m sestamibi or Ga-68 DOTATATE) accounts for approximately 35% of medical revenue. Portable gamma cameras are used for intraoperative tumor localization (e.g., breast cancer sentinel node biopsy) and bedside imaging for critically ill patients who cannot travel to conventional SPECT/CT suites.
Bone Scan (Tc-99m MDP) represents 28% of medical applications. Portable systems enable trauma bay assessment of suspected metastatic disease and follow-up imaging in orthopedic clinics.
Cardiac Stress Test (Tc-99m tetrofosmin or sestamibi) accounts for 22%. Unlike conventional cardiac SPECT requiring dedicated camera rooms, portable gamma imagers equipped with pinhole or parallel-hole collimators permit myocardial perfusion imaging in emergency departments or intensive care units—reducing transfer delays by 45–60 minutes per patient.
Other applications (includes non-medical nuclear security and environmental surveying, which together represent an estimated 270–300millionofthetotal270–300millionofthetotal589 million 2025 market—approximately 47% of overall market). Clinically, portable gamma imagers are not replacements for full SPECT/CT but serve complementary roles: rapid assessment, point-of-care nuclear medicine, and resource-limited settings.
Exclusive observation – the “hybrid deployable” trend (2026): A emerging market bifurcation separates handheld gamma cameras (<5 kg, for security and emergency response) from portable cart-based imagers (15–35 kg, for clinical and environmental use). Handheld units trade energy resolution for portability, while cart-based systems prioritize spectroscopic precision. The 2025 Red Cross CBRN response guidelines specifically added handheld radiation detection imagers to first-responder equipment lists for nuclear incidents. Several manufacturers are developing modular units—same detector head, interchangeable collimator (coded aperture for survey, pinhole for imaging)—allowing flexible deployment across security and clinical scenarios.
5. Competitive Landscape & Regional Analysis
Key players include Catalyst MedTech Digirad, Mediso, MIE, DDD Diagnostic, Adolesco AB, Basda, and NUVIATech Instruments.
Regional insights:
- North America leads with 44% market share, supported by Department of Homeland Security (DHS) Domestic Nuclear Detection Office (DNDO) funding and an extensive nuclear medicine infrastructure.
- Europe follows (34%), with France, Germany, and the UK overseeing active decommissioning programs and cross-border radiological monitoring networks.
- Asia-Pacific is the fastest-growing region (CAGR 9.8%), particularly Japan (post-Fukushima decommissioning and environmental monitoring) and China (expanding nuclear power fleet—55 operating reactors, 23 under construction as of March 2026). South Korea’s nuclear safety commission procured 14 portable gamma imagers in 2025 for its five nuclear power plant sites.
Market positioning: Mediso leads in clinical portable gamma cameras (AnyScan, NanoScan) with superior spatial resolution (<2 mm for pinhole collimation). Catalyst MedTech Digirad dominates the US cardiology point-of-care market (Cardius, Ergo) with FDA-cleared systems. NUVIATech Instruments specializes in ultra-portable (<3 kg) CZT-based imagers for nuclear security. Basda holds a niche in coded-aperture imagers for lost-source search.
6. Technical Challenges & Future Outlook
Despite strong growth, the industry faces three technical challenges:
- Sensitivity vs. portability trade-off – Smaller detectors (needed for portability) capture fewer gamma photons, reducing sensitivity and increasing acquisition time (10–30 seconds for survey vs. 1–5 seconds for high-sensitivity backpack detectors). Advanced reconstruction algorithms (maximum likelihood expectation maximization with sparse priors) are partially closing this gap.
- Compton scattering in coded aperture designs – At higher energies (>1 MeV), gamma rays penetrate coded aperture masks before interacting, degrading angular resolution. Hybrid mask designs (tungsten front layer, gadolinium back layer) and time-encoded imaging are active research areas.
- Energy resolution stability over temperature – CZT detectors exhibit gain shifts with ambient temperature (typically 0.5–1.5% per °C), requiring per-unit temperature compensation circuits. Recent digital pulse processing ASICs (application-specific integrated circuits) now incorporate real-time gain stabilization.
From a manufacturing perspective, the industry is transitioning from fully discrete assembly toward modular detector subassemblies (common baseplate + interchangeable collimator + plug-in readout electronics). This modularity reduces custom SKUs and enables faster field servicing—a key requirement for nuclear security end-users operating in remote locations.
7. Conclusion: Strategic Implications for 2026–2032
The Portable Gamma Imager market is positioned for robust growth, underpinned by rising radiological security investments, aging nuclear reactor decommissioning, and expansion of point-of-care nuclear medicine. Success will depend on advancing semiconductor detector yields, improving algorithmic sensitivity, and developing modular platforms that serve both security and clinical markets. The QYResearch report provides essential segment-level forecasts, technology roadmaps, and competitive assessments for device manufacturers, nuclear facility operators, and homeland security agencies.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
